期刊文献+

芪灵益肝煎及其CO_2超临界萃取液对肝癌细胞株H_(22)端粒酶反转录亚单位表达的影响 被引量:2

Effect of serum of mice treated with Qilingyiganjian and its liquid of CO_2 supercritical fluid extraction on telomerase expression in hepatic carcinoma cell line H_(22)
下载PDF
导出
摘要 目的观察芪灵益肝煎、芪灵益肝煎CO2超临界萃取液、环磷酰胺(Cyc)的含药血清对小鼠腹水型肝癌细胞株HcaF25/CL16A3(H22)端粒酶反转录亚单位(TERT)表达的影响。方法利用血清药理学方法,以Cyc为阳性对照,用免疫组化技术观察小鼠腹水型肝癌细胞株H22TERT的表达。结果经大、小剂量芪灵益肝煎、芪灵益肝煎CO2超临界萃取液、Cyc的含药血清作用后小鼠腹水型肝癌细胞株H22TERT的表达均下调,与对照组比较,差异有明显的统计学意义(P<0.01),而下调TERT的程度在4组组间比较差异无统计学意义(P>0.05)。结论大、小剂量芪灵益肝煎、芪灵益肝煎CO2超临界萃取液、Cyc均可下调H22TERT的表达,而且下调TERT的程度相当。 AIM To observe the expression of telomerase reverse transcriptase (TERT)through immunohistochemical technique on hepatocellular carcinoma cell line H 22 after treated with the serum of these drugs: cyclophosphamide(Cyc),Qilingyiganjian(QLYGJ)and its liquid of CO2 supercritical fluid extraction(SFE). METHODS With the method of seropharmacology,the expression of TERT by immunohistochemical technique was studied by contrast of Cyc,that was,positive control. RESULTS The group of Cyc,high and low dose QLYGJ,and its liquid of CO2 SFE had positive expression.Rank sum test showed that the expression of TERT was downsized,and there was apparent deference from that of control group(P<0.01).While among the 4 groups of serum treated with drugs, there were no statistical differences(P>0.05). CONCLUSION All of there drugs:Cyc,big and small dose QLYGJ,the liquid of CO2-SFE can downregulate the expression of TERT,furthermore,the degree of their downregulating TERT makes no statistical difference.
出处 《中国临床药学杂志》 CAS 2005年第3期180-182,共3页 Chinese Journal of Clinical Pharmacy
关键词 肝癌 端粒酶 CO2超临界萃取 telomerase hepatic carcinoma CO2 supercritical fluid extraction
  • 相关文献

参考文献6

二级参考文献24

  • 1周红,颜青,林炳珍,王宇昉,陈瑞川,李忌,郑荣梁,贾忠健.Isoverbascoside对HL-60细胞生长和超微结构的影响[J].癌症,1997,16(1):29-31. 被引量:7
  • 2[1]Story A,Thomas M,Kalita A,et al.Role of a p53 polymorphism in the development of human papillomavirus-associated cancer [ J].Nature,1998,393(21 ): 229-233. 被引量:1
  • 3[2]Iwasaka T,Zheng PS,Yokoyama M,et al.Telomerase activity in cervical neoplasia[J].Obstet Gyneocol,1998,91(2) :260-262. 被引量:1
  • 4[3]Bonn D.,Bradbury J.The warts and approach to tackling cervical cancer[J].Lancet,1998,351(14) :810-818. 被引量:1
  • 5[4]Klingehutz AJ,Foster SA,Mcdougall JK.Telomerase activity by the E6 gene product of human papillomavirus type 16 [ J].Nature,1996,380(6569) :79-82. 被引量:1
  • 6[5]Kondo Y,Kondo S,Tanka Y,et al.Inhibition of telomerase increase the susceptibility of human malignant glioblastoma cells to cisplatininduced apoptosis[ J].Oncogene,1998,16(17) :2243-2248. 被引量:1
  • 7[6]Hector MV,Cristiane G,Bouteiller O,et al.Human germinal center B cells express the apoptosis-inducing genes Fas,c-myc,p53 and Bax but not the survival gene bcl-2[J].J Exp Med,1996,183(3) :971-977. 被引量:1
  • 8[7]Anderson S,Shera K,Ihle J,et al.Telomerase activation in cervical cancer [J].Am J Pathol,1997,151( 1 ): 25-31. 被引量:1
  • 9[8]Ito H,Kyo S,Kanaya T,et al.Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer[J].Clin Cancer Res,1998,4(12): 1603-1608. 被引量:1
  • 10[9]Cole ST,Danos O.Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome[J].J Mol Biol,1987,193(4) :599-608. 被引量:1

共引文献21

同被引文献66

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部